Fc-optimized CD276 antibody enhances NK cell activation against non-small cell lung cancer

Stefanczyk, Sylwia A.; Kaiser, Xenija; Hagelstein, Ilona; Holzmayer, Samuel; Zekri, Latifa; Jung, Susanne; Maerklin, Melanie

dc.contributor.author	Kaiser, Xenija
dc.contributor.author	Hagelstein, Ilona
dc.contributor.author	Holzmayer, Samuel
dc.contributor.author	Zekri, Latifa
dc.contributor.author	Jung, Susanne
dc.contributor.author	Stefanczyk, Sylwia
dc.contributor.author	Märklin, Melanie
dc.date.accessioned	2026-03-30T09:44:35Z
dc.date.available	2026-03-30T09:44:35Z
dc.date.issued	2025
dc.identifier.issn	1664-3224
dc.identifier.uri	http://hdl.handle.net/10900/177879
dc.language.iso	en	de_DE
dc.publisher	Lausanne : Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fimmu.2025.1624751	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Fc-optimized CD276 antibody enhances NK cell activation against non-small cell lung cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20251118000000_01309
utue.personen.roh	Stefanczyk, Sylwia A.
utue.personen.roh	Kaiser, Xenija
utue.personen.roh	Hagelstein, Ilona
utue.personen.roh	Holzmayer, Samuel
utue.personen.roh	Zekri, Latifa
utue.personen.roh	Jung, Susanne
utue.personen.roh	Maerklin, Melanie
dcterms.isPartOf.ZSTitelID	Frontiers in Immunology	de_DE
dcterms.isPartOf.ZS-Issue	Article 1624751	de_DE
dcterms.isPartOf.ZS-Volume	16	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE